Market Research Logo

Tissue Regenix Ltd - Product Pipeline Analysis, 2016 Update

Summary

Tissue Regenix Ltd (Tissue Regenix) is a medical technology company that offers replacement body parts from biological materials by using the dCELL technology platform. The company’s proprietary dCELL technology process is applied in markets such as vascular, cardiac and orthopaedics. It manufactures dCELL vascular patch. Tissue Regenix’s other products include dCELL heart valve, additional applications for the dCELL patch, dCELL meniscus and dCELL (Human) dermis. Tissue Regenix collaborates with universities and other institutions for its research activities. The company markets its products through its network of distributors. Tissue Regenix is headquartered in York, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Tissue Regenix Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Tissue Regenix Ltd Company Overview
Tissue Regenix Ltd Company Snapshot
Tissue Regenix Ltd Pipeline Products and Clinical Trials Overview
Tissue Regenix Ltd – Pipeline Analysis Overview
Key Facts
Tissue Regenix Ltd - Major Products and Services
Tissue Regenix Ltd Pipeline Products by Development Stage
Tissue Regenix Ltd Pipeline Products Overview
Cardiopure - Aortic Heart Valve
Cardiopure - Aortic Heart Valve Product Overview
Cardiopure - Arterial-Vascular Graft
Cardiopure - Arterial-Vascular Graft Product Overview
Cardiopure - Arterial-Vascular Graft Clinical Trial
Cardiopure - Pulmonary Heart Valve
Cardiopure - Pulmonary Heart Valve Product Overview
CardioPure HV
CardioPure HV Product Overview
dCELL - Small Diameter Graft
dCELL - Small Diameter Graft Product Overview
dCELL Human Dermis - Chronic Wounds
dCELL Human Dermis - Chronic Wounds Product Overview
dCELL Human Dermis - Plastic Surgery
dCELL Human Dermis - Plastic Surgery Product Overview
dCELL Porcine Aortic Heart Valve
dCELL Porcine Aortic Heart Valve Product Overview
Dermapure - Acute Wounds
Dermapure - Acute Wounds Product Overview
OrthoPure HM
OrthoPure HM Product Overview
Orthopure HT
Orthopure HT Product Overview
OrthoPure XM
OrthoPure XM Product Overview
OrthoPure XM Clinical Trial
Orthopure XT
Orthopure XT Product Overview
SurgiPure XD
SurgiPure XD Product Overview
Tissue Regenix Ltd - Key Competitors
Tissue Regenix Ltd - Key Employees
Tissue Regenix Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Tissue Regenix Ltd, Recent Developments
Dec 06, 2016: Tissue Regenix Group announces DermaPure secures GPO agreement with Premier
Nov 28, 2016: Tissue Regenix Provides Update on OrthoPure XT
Sep 15, 2016: Tissue Regenix Group: DermaPure - Two Peer Reviewed Clinical Papers Published
Sep 01, 2016: Tissue Regenix Group's DermaPure covered under Medicare in further 10 States
Jul 11, 2016: Tissue Regenix Group Provides Update On OrthoPure XT
Jul 11, 2016: Tissue Regenix Group Provides Update On OrthoPure XM
Jul 01, 2016: Tissue Regenix Group Announces DermaPure secures first GPO contract in US
Apr 14, 2016: Clinical posters further validating the use of Tissue Regenix DermaPure to be displayed at SAWC conference
Mar 09, 2016: Tissue Regenix Group : Further Medicare Coverage for DermaPure
Feb 03, 2016: DermaPure selected to feature nine poster presentations at Woundcare Symposium
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Tissue Regenix Ltd Pipeline Products and Clinical Trials Overview
Tissue Regenix Ltd Pipeline Products by Equipment Type
Tissue Regenix Ltd Pipeline Products by Indication
Tissue Regenix Ltd Clinical Trials by Trial Status
Tissue Regenix Ltd, Key Facts
Tissue Regenix Ltd, Major Products and Services
Tissue Regenix Ltd Number of Pipeline Products by Development Stage
Tissue Regenix Ltd Pipeline Products Summary by Development Stage
Tissue Regenix Ltd Clinical Trials by Trial Status
Tissue Regenix Ltd Clinical Trials Summary
Cardiopure - Aortic Heart Valve - Product Status
Cardiopure - Aortic Heart Valve - Product Description
Cardiopure - Arterial-Vascular Graft - Product Status
Cardiopure - Arterial-Vascular Graft - Product Description
Cardiopure - Arterial-Vascular Graft - A Prospective, Non-comparative Clinical Investigation of a Novel Decellularised Porcine Xenograft (dCELL ACL Scaffold) for Reconstruction of the Anterior Cruciate Ligament
Cardiopure - Pulmonary Heart Valve - Product Status
Cardiopure - Pulmonary Heart Valve - Product Description
CardioPure HV - Product Status
CardioPure HV - Product Description
dCELL - Small Diameter Graft - Product Status
dCELL - Small Diameter Graft - Product Description
dCELL Human Dermis - Chronic Wounds - Product Status
dCELL Human Dermis - Chronic Wounds - Product Description
dCELL Human Dermis - Plastic Surgery - Product Status
dCELL Human Dermis - Plastic Surgery - Product Description
dCELL Porcine Aortic Heart Valve - Product Status
dCELL Porcine Aortic Heart Valve - Product Description
Dermapure - Acute Wounds - Product Status
Dermapure - Acute Wounds - Product Description
OrthoPure HM - Product Status
OrthoPure HM - Product Description
Orthopure HT - Product Status
Orthopure HT - Product Description
OrthoPure XM - Product Status
OrthoPure XM - Product Description
OrthoPure XM - dCell Vascular Patch in Biological Repair for Damaged Menisci for CE Mark Submission
Orthopure XT - Product Status
Orthopure XT - Product Description
SurgiPure XD - Product Status
SurgiPure XD - Product Description
Tissue Regenix Ltd, Key Employees
List of Figures
Tissue Regenix Ltd Pipeline Products by Equipment Type
Tissue Regenix Ltd Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report